Mortimer P P, Parry J V
Hepatitis and Retrovirus Laboratory, Virus Reference Division, Central Public Health Laborayory, 61 Colindale Avenue, London NW9 5HT, UK.
Clin Diagn Virol. 1994 Aug;2(4-5):231-43. doi: 10.1016/0928-0197(94)90048-5.
The possibility that saliva could be used for HIV screening and diagnosis has been known since 1986. Despite the obvious advantages over venepuncture of ease of collection, safety, compliance and cost, interest in salivary testing has grown relatively slowly. Several studies have demonstrated that salivary anti-HIV testing can be highly accurate, particularly if specimen collection procedure are optimal.
To review current knowledge about the detection of anti-HIV in oral fluids, with an emphasis on the identification of optimal procedures.
In the light of existing published data, the factors leading to accurate salivary diagnosis of HIV infection were identified and reviewed.
To achieve the best results it is essential to collect oral fluid specimens that are rich in IgG. Most IgG in the oral cavity derives from the crevicular space between the gums and the teeth, and not from salivary glands. Available methods for collecting salivary specimens are discussed. Until these collection methods are fully validated, individual specimens or at least clinical ones found anti-HIV negative should be tested for total IgG before being reported on. There is a lack of proven confirmatory methods for salivary anti-HIV and this problem is reviewed. Salivary anti-HIV testing has been employed mostly for surveillance, but life insurance applicants are increasingly screened in this way and clinical applications are under active consideration. With appropriate safeguards, diagnostic and pre-blood donation salivary testing could be introduced shortly. The necessary technology is also available to develop rapid single-use salivary tests. This would bring anti-HIV testing closer to the patient.
Salivary tests for anti-HIV offer advantages of convenience, economy and safety, and are more acceptable to subjects than blood tests. Further evaluation of the collection devices and assays, the introduction of safeguards against inadequate sampling and the development of suitable confirmatory assays are required. When these deficiencies have been met, salivary tests may supersede tests on serum for HIV and also other infections.
自1986年以来,人们就已了解唾液可用于HIV筛查和诊断的可能性。尽管与静脉穿刺相比,唾液采集具有明显优势,如采集方便、安全、依从性好且成本低,但唾液检测的关注度增长相对缓慢。多项研究表明,唾液抗HIV检测可以高度准确,尤其是在标本采集程序优化的情况下。
回顾当前关于口腔液中抗HIV检测的知识,重点是确定最佳程序。
根据已发表的现有数据,确定并回顾了导致HIV感染唾液诊断准确的因素。
为获得最佳结果,采集富含IgG的口腔液标本至关重要。口腔中的大多数IgG来源于牙龈与牙齿之间的龈沟间隙,而非唾液腺。讨论了现有的唾液标本采集方法。在这些采集方法得到充分验证之前,个体标本或至少抗HIV检测呈阴性的临床标本在报告前应检测总IgG。目前缺乏经证实的唾液抗HIV确证方法,对此问题进行了回顾。唾液抗HIV检测主要用于监测,但越来越多的人寿保险申请人也通过这种方式进行筛查,临床应用也在积极考虑中。采取适当保障措施后,不久即可引入诊断性和献血前唾液检测。开发快速一次性唾液检测所需的技术也已具备。这将使抗HIV检测更贴近患者。
唾液抗HIV检测具有方便、经济和安全的优点,受试者比血液检测更易接受。需要进一步评估采集装置和检测方法,引入防止采样不足的保障措施,并开发合适的确证检测方法。当这些不足得到解决后,唾液检测可能会取代血清HIV检测以及其他感染检测。